Genitope files $125 million shelf

By Devika Patel

Knoxville, Tenn., Oct. 19 - Genitope Corp. filed a $125 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, warrants and units. Preferred stock may be convertible.

Proceeds will be used for general corporate purposes.

Fremont, Calif.-based Genitope is a biotechnology company specializing on the research and development of novel immunotherapies for the treatment of cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.